Skip to main content
Equibles

CBAV · CLINICA BAVIERA SA · Financials

Use CBAV with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CBAV.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
55.2000 EUR -0.4000 (-0.72%) At close · Oct 5
Rebalance outlook locked
Market Cap
897.50M EUR
Shares
16.03M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →

Browse captured authority reports and their original financial labels

Revenue
301.78M +14.9%
FY2025 Revenue FY2019–FY2025
Net Income
42.06M +4.6%
FY2025 Net Income FY2019–FY2025
Operating Margin
20.06% -1.1pp
FY2025 Operating Margin FY2019–FY2025
Operating Cash Flow
76.84M +22.9%
FY2025 Operating Cash Flow FY2019–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
EUR 301.78M 262.65M 224.92M 198.45M 172.73M 122.63M 124.33M
EUR 23.9M 20.88M 16.98M 15M 14.09M 13.55M 13.23M
EUR 60.54M 55.67M 50.01M 41.49M 39.43M 20.51M 18.32M
EUR 2.28M 1.22M 571.65K 418.83K 458.3K 535.09K 591.69K
EUR 60.11M 55.99M 49.65M 40.68M 38.9M 20.19M 17.79M
EUR 17.18M 14.86M 12.92M 10.53M 10.97M 6.05M 4.89M
EUR 42.06M 40.21M 35.97M 29.52M 27.39M 13.94M 12.79M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2019–FY2025: 14.76M in buybacks, 110.05M in dividends.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.